These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20505100)

  • 21. Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitizing motor behaviours.
    Lane EL; Cheetham SC; Jenner P
    Eur J Neurosci; 2005 Jan; 21(1):179-86. PubMed ID: 15654855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.
    Maries E; Kordower JH; Chu Y; Collier TJ; Sortwell CE; Olaru E; Shannon K; Steece-Collier K
    Neurobiol Dis; 2006 Jan; 21(1):165-80. PubMed ID: 16095907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium nitroprusside enhances stepping test performance and increases medium spiny neurons responsiveness to cortical inputs in a rat model of Levodopa-induced dyskinesias.
    Ribeiro DL; Guimarães RP; Bariotto-Dos-Santos K; Del Bel E; Padovan-Neto FE
    Eur J Neurosci; 2024 Apr; 59(7):1604-1620. PubMed ID: 38359910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
    Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
    Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia.
    Engeln M; Bastide MF; Toulmé E; Dehay B; Bourdenx M; Doudnikoff E; Li Q; Gross CE; Boué-Grabot E; Pisani A; Bezard E; Fernagut PO
    Biol Psychiatry; 2016 Mar; 79(5):354-361. PubMed ID: 25146322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia.
    Lundblad M; Vaudano E; Cenci MA
    J Neurochem; 2003 Mar; 84(6):1398-410. PubMed ID: 12614340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats.
    Sgroi S; Capper-Loup C; Paganetti P; Kaelin-Lang A
    Exp Neurol; 2016 Jun; 280():80-8. PubMed ID: 27072528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal ΔFosB gene suppression inhibits the development of abnormal involuntary movements induced by L-Dopa in rats.
    Beck G; Zhang J; Fong K; Mochizuki H; Mouradian MM; Papa SM
    Gene Ther; 2021 Dec; 28(12):760-770. PubMed ID: 33707771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression pattern of JunD after acute or chronic L-DOPA treatment: comparison with deltaFosB.
    Valastro B; Andersson M; Lindgren HS; Cenci MA
    Neuroscience; 2007 Jan; 144(1):198-207. PubMed ID: 17055656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
    Cenci MA
    Amino Acids; 2002; 23(1-3):105-9. PubMed ID: 12373525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Yang X; Zhao H; Shi H; Wang X; Zhang S; Zhang Z; Zu J; Zhang W; Shen X; Cui G; Hua F
    Exp Neurol; 2015 Sep; 271():168-74. PubMed ID: 26001615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat.
    Lebel M; Chagniel L; Bureau G; Cyr M
    Neurobiol Dis; 2010 Apr; 38(1):59-67. PubMed ID: 20060905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.
    Agnati LF; Leo G; Vergoni AV; Martínez E; Hockemeyer J; Lluis C; Franco R; Fuxe K; Ferré S
    Brain Res Bull; 2004 Aug; 64(2):155-64. PubMed ID: 15342103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors.
    Cote SR; Chitravanshi VC; Bleickardt C; Sapru HN; Kuzhikandathil EV
    Behav Brain Res; 2014 Apr; 263():46-50. PubMed ID: 24462727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease.
    Oeckl P; Hengerer B; Ferger B
    Exp Neurol; 2014 Jul; 257():1-9. PubMed ID: 24747358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2.
    Morgese MG; Cassano T; Gaetani S; Macheda T; Laconca L; Dipasquale P; Ferraro L; Antonelli T; Cuomo V; Giuffrida A
    Neurochem Int; 2009 Jan; 54(1):56-64. PubMed ID: 19010365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.
    Collier TJ; O'Malley J; Rademacher DJ; Stancati JA; Sisson KA; Sortwell CE; Paumier KL; Gebremedhin KG; Steece-Collier K
    Neurobiol Dis; 2015 May; 77():191-203. PubMed ID: 25771169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias.
    Delfino MA; Stefano AV; Ferrario JE; Taravini IR; Murer MG; Gershanik OS
    Behav Brain Res; 2004 Jul; 152(2):297-306. PubMed ID: 15196797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats.
    Papathanou M; van der Laan R; Jenner P; Rose S; McCreary AC
    Mov Disord; 2013 Jul; 28(8):1072-9. PubMed ID: 23125107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease.
    Westin JE; Andersson M; Lundblad M; Cenci MA
    Eur J Neurosci; 2001 Oct; 14(7):1171-6. PubMed ID: 11683909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.